Ruyue Wang

848 total citations
44 papers, 616 citations indexed

About

Ruyue Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ruyue Wang has authored 44 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Ruyue Wang's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (10 papers) and RNA modifications and cancer (9 papers). Ruyue Wang is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (10 papers) and RNA modifications and cancer (9 papers). Ruyue Wang collaborates with scholars based in China, Czechia and Australia. Ruyue Wang's co-authors include Liqun Xia, Zeyi Lu, Gonghui Li, Lifeng Ding, Qiming Zheng, Danyang Shen, Huan Wang, Haiyun Xie, Chenhao Yu and Wenqin Luo and has published in prestigious journals such as Scientific Reports, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Ruyue Wang

39 papers receiving 611 citations

Peers

Ruyue Wang
Tao Guo China
Fukushi Abekura South Korea
Dengke Li China
Yao Cheng China
Tao Guo China
Ruyue Wang
Citations per year, relative to Ruyue Wang Ruyue Wang (= 1×) peers Tao Guo

Countries citing papers authored by Ruyue Wang

Since Specialization
Citations

This map shows the geographic impact of Ruyue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyue Wang more than expected).

Fields of papers citing papers by Ruyue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyue Wang. The network helps show where Ruyue Wang may publish in the future.

Co-authorship network of co-authors of Ruyue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyue Wang. A scholar is included among the top collaborators of Ruyue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyue Wang. Ruyue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ruyue, Fan Li, Zeyi Lu, et al.. (2025). piR‐RCC Suppresses Renal Cell Carcinoma Progression by Facilitating YBX‐1 Cytoplasm Localization. Advanced Science. 12(30). e14398–e14398.
2.
3.
Song, Yang, Shanshan Zhang, Ruyue Wang, et al.. (2025). Ginseng as promising natural medicine against infectious diseases: Therapeutic targets and potential mechanisms. Journal of Ethnopharmacology. 356. 120764–120764.
4.
Wang, Yuying, Ruyue Wang, Yun Jiang, et al.. (2024). Comparative study on static and dynamic digest characteristics of oat β-Glucan and β-Gluco-Oligosaccharides. Food Research International. 197(Pt 1). 115153–115153. 4 indexed citations
5.
Luo, Wenqin, Fan Li, Lifeng Ding, et al.. (2024). m6Am Methyltransferase PCIF1 Promotes LPP3 Mediated Phosphatidic Acid Metabolism and Renal Cell Carcinoma Progression. Advanced Science. 11(46). e2404033–e2404033. 4 indexed citations
6.
He, Qingwen, Yaling An, Xuemei Zhou, et al.. (2024). Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies. Med. 5(5). 401–413.e4. 11 indexed citations
7.
Luo, Wenqin, Huan Wang, Zeyi Lu, et al.. (2023). HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p. Cell & Bioscience. 13(1). 153–153. 6 indexed citations
8.
Liu, Yue, Yuan Yuan, Ruyue Wang, et al.. (2023). Mitochondrial pyruvate carrier 1 alleviates hypoxic-ischemic brain injury in rats. Life Sciences. 325. 121686–121686. 6 indexed citations
9.
Li, Yang, Zeyi Lu, Qiming Zheng, et al.. (2023). Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC. Cellular Signalling. 111. 110888–110888. 2 indexed citations
10.
Wang, Ruyue, Xiuyi Pan, Zhengzheng Su, et al.. (2023). A novel intronic circular RNA circFGFR1int2 up-regulates FGFR1 by recruiting transcriptional activators P65/FUS and suppressing miR-4687-5p to promote prostate cancer progression. Journal of Translational Medicine. 21(1). 840–840. 4 indexed citations
11.
Chen, Yuanlei, Zeyi Lu, Chao Qi, et al.. (2022). N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Molecular Cancer. 21(1). 111–111. 78 indexed citations
12.
Xie, Haiyun, Mingchao Wang, Huan Wang, et al.. (2022). METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m7G-modified miR-760-dependent manner. Cell Death Discovery. 8(1). 458–458. 25 indexed citations
13.
Wen, Wuwu, Ruyue Wang, Liantai Su, et al.. (2021). MsWRKY11, activated by MsWRKY22, functions in drought tolerance and modulates lignin biosynthesis in alfalfa (Medicago sativa L.). Environmental and Experimental Botany. 184. 104373–104373. 40 indexed citations
14.
Wang, Ruyue, Yiyao Liu, Qian Zhang, et al.. (2021). HM-3-HSA exhibits potent anti-angiogenesis and antitumor activity in hepatocellular carcinoma. European Journal of Pharmaceutical Sciences. 167. 106017–106017. 6 indexed citations
15.
Shen, Danyang, Lifeng Ding, Zeyi Lu, et al.. (2021). METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Molecular Therapy — Nucleic Acids. 27. 547–561. 46 indexed citations
16.
Ding, Lifeng, Ruyue Wang, Danyang Shen, et al.. (2021). Role of noncoding RNA in drug resistance of prostate cancer. Cell Death and Disease. 12(6). 590–590. 50 indexed citations
17.
Wang, Ningbo, et al.. (2021). Ursolic acid ameliorates amyloid β-induced pathological symptoms in Caenorhabditis elegans by activating the proteasome. NeuroToxicology. 88. 231–240. 21 indexed citations
19.
Ding, Lifeng, Minxiao Jiang, Ruyue Wang, et al.. (2020). The emerging role of small non-coding RNA in renal cell carcinoma. Translational Oncology. 14(1). 100974–100974. 13 indexed citations
20.
Xiao, Wenjun, et al.. (2017). Evaluation of rice tetraticopeptide domain-containing thioredoxin as a novel solubility-enhancing fusion tag in Escherichia coli. Journal of Bioscience and Bioengineering. 125(2). 160–167. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026